PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 147.00
-1.00 (-0.68%)
Jul 15, 2026, 3:39 PM WIB
IDX:LABS Market Cap
IDX:LABS has a market cap or net worth of 584.6 billion as of July 14, 2026. Its market cap has increased by 8.82% in one year.
Market Cap
584.60B
Enterprise Value
593.01B
Revenue
205.85B
Ranking
n/a
PE Ratio
48.44
Stock Price
147.00
Market Cap Chart
Since July 10, 2024, IDX:LABS's market cap has increased from 541.15B to 584.60B, an increase of 8.03%. That is a compound annual growth rate of 3.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 584.60B | 8.03% |
| Dec 30, 2025 | 541.15B | 2.24% |
| Dec 30, 2024 | 529.30B | -2.19% |
| Jul 10, 2024 | 541.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 134.63T |
| PT Kalbe Farma Tbk. | 32.81T |
| PT Siloam International Hospitals Tbk | 28.05T |
| PT Mitra Keluarga Karyasehat Tbk | 23.71T |
| PT Kedoya Adyaraya Tbk | 994.75B |
| PT Charlie Hospital Semarang Tbk | 747.30B |
| PT Itama Ranoraya Tbk | 569.95B |
| PT. Penta Valent Tbk | 540.28B |